Liviniti Partners with Mark Cuban's Cost Plus Drug Company to Enhance Prescription Savings

Liviniti, a trusted leader in the pharmacy benefit management (PBM) industry, known for its commitment to transparency and delivering prescription drug savings, is thrilled to announce its partnership with the Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). By adding Cost Plus Drugs to its network of pharmacies, Liviniti aims to further enhance medication accessibility, promote price transparency, and ensure affordability for its members. This collaboration represents a shared vision between two like-minded companies dedicated to simplifying the pharmaceutical landscape and empowering individuals to make informed decisions about their healthcare. Through this alliance, Liviniti continues its mission to revolutionize pharmacy benefits with integrity, innovation, and genuine value for those it serves.

Previous
Previous

Johnson & Johnson Seeks FDA Approval for DARZALEX FASPRO® in Expanded Treatment Regimens

Next
Next

AyuVis Granted FDA Approval for Human Trials of Immunotherapy AVR-48 in Inflammation and Infection